Sofinnova Ventures »

Immunome shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-03-31 $15M 594k 24.68

More positions owned by Sofinnova Ventures

Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Aerovate Therapeutics (AVTE)
Merck & Co (MRK)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Novo-Nordisk A S Adr (NVO)
Incyte Corporation (INCY)
Argenx SE Sponsored Adr (ARGX)
Intuitive Surgical (ISRG)
Dyne Therapeutics (DYN)
Inhibrx (INBX)
Elanco Animal Health (ELAN)
IDEXX Laboratories (IDXX)
AstraZeneca Sponsored Adr (AZN)

View all positions for Sofinnova Ventures

Top funds holding Immunome

Redmile Group
FMR
EcoR1 Capital
T. Rowe Price Associates
Vanguard Group
Point72 Asset Management
Henderson Group
T. Rowe Price Investment Management
Woodline Partners
Avidity Partners Management
BlackRock
Tang Capital Management
Brown Advisory Holdings Incorporated
Sofinnova Ventures
Farallon Capital Management

View all funds holding Immunome